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Abstract
The objective of this study was to evaluate the biological effects of roasted Cashew nuts
consumption on biochemical and murinometric parameters in dyslipidemic rats receiving
lipid supplementation. Young male rats were randomly assigned to three experimental
groups (n = 10). The Control group (CONT) was treated with water, the Dyslipidemic group
(DL) received a high fat content emulsion throughout the experiment, and the Dyslipidemic
Cashew Nuts group (DLCN) received the same high fat content emulsion throughout the
experiment, yet was treated with Cashew nuts. Body parameters, biochemical, hepatic and
fecal fatty acid profiles were all evaluated. The levels of total cholesterol and triglycerides
were higher in the DL and DLCN groups as compared to the control group. DLCN and
CONT presented no difference in HDL levels. DLCN presented higher glycemia levels than
the other groups. There was reduction of body fat in DLCN as compared to other groups,
but with higher accumulations of liver fat. DLCN presented a reduction in saturated hepatic
fatty acids of 20.8%, and an increase of 177% in relation to CONT; there was also a 21% in
increase DL forω9 fatty acids in comparison to CONT. As for fecal fatty acids, there was a
lower concentration of polysaturates in DLCN as compared to the other groups. The data
showed that the consumption of Cashew nuts by the dyslipidemic animals treated with a
hyperlipidic diet induced greater accumulations of liver fat and worsened glycemic levels,
despite having reduced visceral fats and increased fecal fat excretion.
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Introduction
Oleaginous consumption in the population has increased considerably in recent years with
worldwide growth estimated at 59% for the consumption of seed oils during the last decade.
The most popular oleaginous nuts are Almonds (Prunus amigdalis), Hazelnuts (Corylus avel-
lana), Pecans (Juglans regia), Brazil nuts (Bertholletia excelsa), Cashews (Anacardium occiden-
tale), Pistachios (Pistachia vera), Pine nuts (Pinus pinea) and Macadamia nuts (Macadam
integrifolia) [1].
Studies have evidenced the benefit of seed oils for human health [1], in particular the cho-
lesterol-lowering effect [2], as well as cardioprotective effects of almonds [3], and reduction of
inflammatory markers promoted by consumption of nuts in general [4]. Maternal consump-
tion of Cashew nuts in rats has been investigated for causing alterations in offspring develop-
ment [5], from acceleration of nervous system maturation, to prevention memory deficits.
However, there are still few studies investigating the biological effects of Cashew nut seed oil in
non-healthy populations.
Cashews are the fruit of the cashew tree (Anacardium occidentale), which when dried or
roasted, originate Cashew nuts (also known as Cashews). Cashews are a tropical fruit native to
northeastern Brazil, produced in large scale in India and Vietnam [6, 7] with global production
from 2015 to 2016 reaching 738,861 tons [8]. Statistical data show a 70% increase in Cashew
nut exports originating in these countries. The USA is the principal importer, but the popula-
tion with the highest per capita consumption is Cambodia [8].
Cashew nuts are consumed in their natural or roasted form, or converted into food by-
products [7]. Having a soft and slightly sweet flavor, they stand out for high lipid content (47.8
g/100g) as source of unsaturated fatty acids (UFAs)—oleic (ω-9) and linoleic (ω-6) acid [9, 5].
Other functional properties of the seed oil are due to its phenolic contents (flavonoids, antho-
cyanins and tannins), and fiber [10]. The most valuable micronutrients found in cashews are
folate and tocopherols [11], which delay metabolic disorders, protecting against atherosclerosis
and other chronic non-communicable diseases (CNCD) [12].
Cardiovascular disease is the most prevalent of CNCDs and responsible for almost 1/3 of
deaths worldwide. The main risk factors for CNCDs are obesity, smoking, hypertension and
dyslipidemias [13]. Adequate food habits are essential to control dyslipidemia; both fiber and
unsaturated fatty acids help control dyslipidemia. Cashew nuts is a source of fiber and UFAs
could be a food that helps control dyslipidemia [14]. We hypothesize that consumption of
cashew nuts improves dyslipidemia in rats with a hyperlipidic diet. The objective of this
research was to evaluate biological effects on biochemical and murinometric parameters of
consuming cashew nuts in dyslipidemic rats who did not modify the hyperlipidic diet to nor-
molipidic diet.
Methods and materials
This study was approved by the UFCG Ethics Committee for Animal Use (Protocol No. 94–
2017). The experimental protocol followed the ethical recommendations of the National Insti-
tute of Health Bethesda (Bethesda, USA) regarding animal care (Fig 1). The research was duly
registered in the National System of Management of Genetic Heritage and Traditional Knowl-
edge (SISGEN), under Code A1BE84C.
Plant material (cashew nuts)
Roasted cashew nuts were acquired in a local store in the city of Cuité, located in the Curima-
taú region of Paraı́ba. For better administration of the Cashew nuts to the animals, the Cashew
nuts were crushed to flour. For this, the Cashew nuts were chilled to (± 4˚C) to avoid
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temperature increases during processing; and loss of nutritional properties. A household
blender was used to obtain the homogeneous flour which was then stored under refrigeration
in a hermetically sealed container and unexposed to luminosity throughout the experiment.
Nutritional characterization of the cachew nuts
Cashew nut flour was subjected to analysis to characterize its centesimal composition, fiber
quantification, phenolic contents and total flavonoids (Table 1), as also analysis of phenolic
compounds by High-performance liquid chromatography (HPLC) (Table 2). For centesimal
composition; moisture, ash, lipids and proteins [15] were analyzed. Calculation of the total car-
bohydrate content was estimated by difference: using the AOAC formula [15]: 100-[Weight in
grams (protein + lipids + ashes + water) in 100 g of food]. To quantify dietary fiber, the meth-
odology described by Prosky et al. [16]. All analyses were performed in three replications and
the results presented as mean and standard deviation.
For evaluation of total phenolic and total flavonoids, the Cashew nut constituents were
extracted with an 80% methanol solution (v/v). One gram of Cashew nut was measured into a
test tube and 10 mL of solvent was added. The test tube was left at room temperature for 24
hours and after filtration the volume was completed to 10 mL with an extraction solvent and
stored in a freezer (-18˚C) until analysis. Total phenolic compounds were quantified according
to the methodology described by Liu et al. [17], with modifications: 250 μL of extract was
Fig 1. Experimental protocol. Sequence of time in days specifying procedures that were performed with dyslipidemic
rats fed with cashew nuts, dyslipidemic control group and normal control group. (�) Days of monitoring of body
weight and feed intake. Physical parameters, blood collection, adipose tissue and liver were performed on the same day
of euthanasia.
https://doi.org/10.1371/journal.pone.0225736.g001
Table 1. Centesimal composition from the diet and cashew nut.
Nutrient (g/Kg) Diet
(commercial chow)
Cashew nut
Carbohydrates 630 349.2 ± 0.0
Fat 40 372.3 ± 23.4
Protein 230 210.2 ± 7.3
Moisture 40 41.9 ± 0.7
Dry matter 60 26.4 ± 0.2
Total fibers - 36.531 ± 0.0
Soluble fibers - 3.311 ± 0.0
Insoluble fibers - 33.220 ± 0.0
Total phenolics (mg GAE/100g) - 80.20 ± 0.001
Total flavonoids (mg CE/100g) - 6.90 ± 0.73
https://doi.org/10.1371/journal.pone.0225736.t001
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mixed with 1250 μL of a 1:10 diluted Folin–Ciocalteau reagent. The solutions were mixed thor-
oughly and incubated at room temperature (27˚C) for 6 min. After incubation, 1000 μL of
7.5% sodium carbonate (Na2CO3) solution was added and again incubated in a water bath at
50˚C for 5 min. The reaction mixtures’ absorbances were measured at 765 nm using a spectro-
photometer (BEL Photonics, Piracicaba, São Paulo, Brazil). The absorbance of the extract was
compared with a gallic acid standard curve for estimating concentration of total phenolic com-
pounds in the sample. The results were expressed in mg of gallic acid equivalents (GAE) per
hundred grams of Cashew nut on the basis of dry weight.
The total flavonoid content was measured using the colorimetric assay developed by
Zhishen et al. [18]. A known volume (0.5 mL) of the extract was added to a test tube and at the
same time 150 μL of 5% NaNO2 was added. After 5 min, 150 μL of 10% AlCl3 was added, and,
at 6 min, 1 mL of 1 M NaOH was added, followed by 1.2 mL of distilled water. Sample absor-
bance was read at 510 nm using a spectrophotometer (BEL Photonics, Piracicaba, São Paulo,
Brazil), and for estimating the concentration of flavonoid contents in the sample, it was com-
pared with a catechin standard curve. The flavonoids content was expressed as mg of catechin
equivalents (QE) per hundred grams of Cashew nut on the basis of dry weight.
The extraction, identification and quantification of phenolic acids from the cashew nuts
were performed according to Meireles (19). For this, the milled sample was degreased with
chloroform and methanol, ethanol 70% was added in proportion sample:solvent 1:10, stirred
for 4h at 200 rpm under temperature control (26˚ C), centrifuged for 15 minutes at 5000 rpm.
Then it was vacuum filtered with Buchner funnel. The extract was dried in a circulating air
oven and eluted in water at a concentration of 5mg/mL and then injected into HPLC following
the methodology mentioned [19].
Animals and diets
Seven-week-old Wistar rats were randomly separated into three experimental groups (n = 10).
Throughout the experiment all the animals were offered access (ad libitum) to water and
Table 2. Profile of phenolic components by HPLC present in cashew nuts.
Name Amount (mg/100 g of cashew nut degreased)
Phenolic acids
3,4-dihydroxy benzoic 200.78 ± 2.68
P-coumaric 10.71 ± 1.78
Syringic 20.52 ±6.25
Trans-Cinnamic 2.68 ± 0.89
Vanillic 29.45 ± 4.46
Ferulic 12.49 ± 0.00
Ellagic 59.79 ± 8.03
Caffeic 41.05 ± 3.57
Gallic 11.60 ± 0.89
Flavonoids
Rutin 49.97 ± 7.14
Miricetin 37.48 ± 1.78
Quercetin 6.25 ± 0.89
Catechin 1650.82 ± 203.45
Total 2133,57
Values are expressed as mean ± SEM.
https://doi.org/10.1371/journal.pone.0225736.t002
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commercial chow (Presence Purina1), being housed individually in metabolic cages, in rooms
with a 12 hours light/dark cycle, light phase starting at 6:00 a.m., with environmental tempera-
ture from 22 to 25˚C, and relative humidity of ± 65%. The experimental groups formed were:
the control group (CONT), receiving water by gavage; the Dyslipidemic Group (DL), receiving
emulsion with high lipid content by gavage; and the Dyslipidemic Cashew Nut Group (DLCN),
receiving an emulsion with high lipid content and Cashew nut flour by gavage.
The animals of the DL and DLCN groups underwent induction of dyslipidemia through
administration of a lipid emulsion during the initial 14 days of the experiment, in the amount
of 1 mL/100 g of the animal’s weight, according to the methodology described by Xu et al.
[20]. The emulsion contained pork lard, cholesterol, glycerol, propylthioracyl, and distilled
water. After the initial 14 days, the formulation of the lipid emulsion was altered by removing
the propylthioracyl and reducing the total quantity by half to 0.5 mL/100 g. Administrations
continued to the DL and DLCN groups until the end of the experiment. Together with the
lipid emulsion, the DLCN group animals received 1 g (4 g/kg of animal weight) of Cashew nut
flour for 28 days.
Physical parameters
Weight and feed intake verifications were performed weekly. The calorie intake was calculated
from feed, emulsion with high lipid content intake and cachew nuts intake. At the end of the
experiment, with the animal anesthetized, the nasal-anal length, and the abdominal and tho-
racic circumferences were measured by measuring tape. The body mass index (BMI) of the
animals was calculated from the body weight (p) and nasal-anal length (c) data using the for-
mula: BMI = p/c2, being weight (p) in grams, and length (c) in centimeters [21].
Biochemical parameters
At the end of the experiment, the blood samples were obtained after cardiac puncture with the
animals anesthetized using ketamine hydrochloride + xilasine hydrochloride (1 mL/kg of
weight). Plasma was collected by centrifugation of the blood at 3,500 rpm for 15 min. The
plasma was used to quantify total cholesterol (TC), HDL, triglycerides (TG) and blood glucose
using the enzyme kit (LABTEST), with later spectrophotometer reading (Spectrophotometer
SP 1102).
Oral glucose tolerance test
The oral glucose tolerance test (OGTT) was performed at the end of the experiment on the 41st
experimental day. The animals at 6 hours of fasting received a 10% sucrose solution at 2 mL/
100 g of weight. Blood was collected through the caudal vein. Glycemia was verified using an
AccuCheck Active glucometer (Roche Diagnostics GmbH, Germany) at 0, 15, 30 and 45 min-
utes after administration of the solution.
The glucose area under the curve (AUC) were calculated as follows:
AUC mg h=dLð Þ ¼
PG ð0Þ þ PG ð15Þ x 2þ PG ð30Þ x 3þ PG ð45Þ x 2
4
Where, PG is plasma glucose.
Visceral, retroperitoneal and hepatic fats
Shortly after euthanasia, the visceral (mesenteric and epididymal) and retroperitoneal fats
were removed and weighed [22]. The liver was removed, weighed and subjected to fat
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quantification by means of the methodology described by Folch et al. [23], and beginning
from a 2 g lipid extraction of the sample using 40 mL of a chloroform: methanol (2:1) solution.
Fecal fat
The feces of the animals were collected in two periods of the study. The first collection took
place at the end of dyslipidemia induction on the 14th experimental day, and the second was
performed at the end of the third week of treatment—on the 35th experimental day. The Folch
et al. [23] methodology was used for fecal fat quantification.
Hepatic and fecal fatty acids
Parts of the liver and feces samples from the animals were used for fatty acid quantification.
Methylation of the fatty acids present in the lipid extract was carried out for both, following
the methodology described by Hartman and Lago [24]. An aliquot of the lipid extract was
taken, calculated for each sample according to the fat content found in the lipid measurement;
and quantification was performed according to the method of Folch et al. [23]. Adding 1 mL
of internal standard (C19:0) and a saponification (KOH) solution, the solution was subse-
quently heated under reflux for 4 min. An esterification solution was then added immediately
afterwards, returning the solution to heating under reflux for 3 extra minutes. The sample was
then allowed to cool before subsequent washings with ether, hexane, and distilled water; finally
obtaining an extract (with the methyl esters and solvents), which was conditioned into a prop-
erly identified amber glass until complete drying of the solvents. After drying, a suspension
was made (in 1 mL of hexane) and packaged into a vial for further chromatographic analysis.
The aliquots of the saponification and esterification solutions were determined according to
the methodology described by Hartman and Lago [24].
A gas chromatograph (VARIAN 430-GC, California, USA), coupled to a fused silica capil-
lary column (CP WAX 52 CB, VARIAN, California, USA) with dimensions of 60 m x 0.25
mm, and a 0.25 mm film thickness was used with helium as the carrier gas (1 mL/min flow
rate). The initial temperature was 100˚C programmed to reach 240˚C, increasing 2.5˚C per
minute for 30 min, totaling 86 minutes. The injector temperature was maintained at 250˚C
and the detector at 260˚C. 1.0 μL aliquots of esterified extract were injected in a Split/Splitless
injector. The chromatograms were recorded using Galaxie Chromatography Data System soft-
ware. Fatty acids were identified by comparing the retention times for the methyl esters of the
samples against Supelco Mix C4-24/C19 standards. The fatty acid results were quantified by
normalizing the areas of the methyl esters, and are expressed as percentage of area.
Statistical analysis
The Cashew nuts flour composition result was described as mean ± S.D. All other results were
expressed as mean ± S.E.M. The statistical analysis of the data was based on one-way ANOVA
followed by a Tukey’s test. Differences were considered significant when p< 0.05. The statisti-
cal analyses were performed using the GraphPad Prism 7 statistical software.
Results
Phenolic compounds
The identification and quantification by HPLC of cashew nut phenolic components is shown
in Table 2. Thirteen phenolic compounds were identified among phenolic acids and flavo-
noids. The highest concentrations were found in 3,4-dihydroxy benzoic acids (200.78 ± 2.68),
Ellagic acid (59.79 ± 8.03) and catechin (1650.82 ± 203.45).
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Body weight
As for the weekly weight of the animals in the respective second and third weeks of the experi-
ment, it was found that the groups undergoing the dyslipidemic induction and treatment tran-
sitions (DL 207.5 ± 3.44 g; 220.5 ± 4.31 g) and (DLCN 211.75 g ± 2.02; 223.6 ± 2.87 g)
presented lower weights in relation to the control group (CONT 228.2 ± 4.61 g; 248.6 ± 4.73 g)
(P< 0.05). In the fourth week, the reduction in weight continued only for the DLCN
(242.6 ± 5.89 g) in relation to the CONT (266.0 ± 4.88 g), and in the fifth week, the DLCN
(248.2 ± 4.75 g) also presented lower weights as compared to the other two experimental
groups, CONT (277.3 ± 5.12 g), and DL (275.14 ± 6.05 g) (P < 0.05) (Fig 2).
Food and calories intake
During dyslipidemia induction, the DL (121.0 ± 3.65 g; 102.3 ± 2.35 g) and DLCN (122.0 ±
5.67 g; 99.12 ± 3.44 g) groups consumed less ration as compared to CONT (139.7 ± 2.45 g;
162.0 ± 3.20 g) (P < 0.05). In the third and fourth week the DL group (124.8 ± 6.06 G;
130.0 ± 3.18 g) consumed even less ration as compared to CONT (160.0 ± 2.73 G; 162.2 ± 2.65
g). In the fourth week of the experiment the DLCN (110.2 ± 4.26 g) also presented lower feed
intake in relation to CONT (162.2 ± 2.65 g), and in the other weeks consumed less ration than
the other groups as well (P< 0.05) (Fig 3).
The caloric intake presented in Table 3 shows that CONT consumed more calories from
the high feed intake compared to the other groups in the first experimental weeks. In the last
two experimental weeks, DLCN consumed fewer calories compared to the other groups.
BMI, abdominal and thoracic circumferences
In Table 4, the BMI, abdominal and thoracic circumference values of the experimental groups
are described. No significant differences were observed between the groups (P> 0.05).
Biochemical analysis
The biochemical analyses proved the efficacy of the dyslipidemia inductions since both the DL
(69.59 ± 4.39 mg/dl) and DLCN (122.52 ± 12.95 mg/dl) groups had high levels of total
Fig 2. Weekly body weight of rats with a hyperlipidaemic diet treated with cashew nut. Values are the
mean ± SEM. Control group (CONT), Dyslipidemic group (DL), Dyslipidemic Cashew Nut group (DLCN). � versus
CONT. # versus DL. p< 0.05, as determined by One-Way ANOVA followed by the Tukey test.
https://doi.org/10.1371/journal.pone.0225736.g002
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cholesterol in relation to the CONT (43.72 ± 2.47 mg/dl) (P< 0.05). DLCN also presented
higher values than DL (P< 0.05). The DL group presented higher serum triglyceride values
(127.4 ± 12.56 mg/dl) as compared to CONT, while DLCN (81.56 ± 5.26 mg/dl) presented ele-
vated triglycerides in relation to CONT (62.76 ± 6.24 mg/dl) and reduced triglycerides as com-
pared to DL (P < 0.05).
HDL levels were similar for the group treated with Cashew nuts and the control group, but
were higher in the DLCN (48.17 ± 3.53 mg/dl) than in the DL (29.55 ± 2.89 mg/dl) (P< 0.05).
In the DL group, the HDL content was lower than in the CONT group (45.28 ± 5.46 mg/dl)
(P< 0.05).
Regarding glycemic levels, DLCN (367.65 ± 12.48 mg/dl) presented higher values than the
other groups (DL 311.39 ± 8.59 mg/dl, and CONT 251.54 ± 9.56 mg/dl). However, the DL
group also presented elevated glycemia as compared to CONT (P < 0.05) (Fig 4).
Oral tolerance test for glucose (OTTG)
During OTTG, the animals of the DLCN (104.20 ± 2.97 mg/dl; 132.78 ± 6.05 mg/dl) and DL
(114.11 ± 2.83 mg/dl; 135.1 ± 4.93 mg/dl) groups had higher glycemic peaks in relation to
CONT (92.0 ± 3.18 mg/dl; 112.5 ± 3.76 mg/dl), respectively at times 0 (zero) and 45 min. At 30
min, only DL (145.11 ± 3.68 mg/dl) presented an increase as compared to CONT
(119.33 ± 5.25 mg/dl) (P< 0.05) (Fig 5A).
Fig 3. Weekly feed intake of dyslipidemic rats treated with cashew nut. Values are the mean ± SEM for the
following groups: Control group (CONT), Dyslipidemic group (DL), Dyslipidemic Cashew Nut group (DLCN). �
versus CONT. # versus DL. p< 0.05, as determined by One-Way ANOVA followed by the Tukey test.
https://doi.org/10.1371/journal.pone.0225736.g003
Table 3. Calorie intake (Kcal) of dyslipidemic rats treated with cashew nuts.
Week CONT DL DLCN
1 530.86 ± 9.30a 471.19 ± 13.99b 483.02 ± 21.63ab
2 615.60 ± 12.15a 399.01 ± 8.93b 382.73 ± 15.43b
3 608.00 ± 10.36a 485.45 ± 23.28b 423.98 ± 12.36b
4 618.86 ± 10.07a 506.87 ± 14.48b 488.05 ± 16.42b
5 628.90 ± 15.18a 593.39 ± 15.79a 436.72 ± 12.36b
6 601.35 ± 11.88a 591.34 ± 9.24a 547.38 ± 4.83b
Values are expressed as mean ± SEM. Different letters in the same row differ significantly (p < 0.05) between the samples.
https://doi.org/10.1371/journal.pone.0225736.t003
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Still analyzing the Fig 5, we can follow the OTTG results through the glucose area over the
curve (Fig 5B), showing higher glucose levels for the DL group (926.99 mg h/dL), followed by
the DLCN (866.91 mg h/dL) compared to CONT (771.04 mg h/dL).
Visceral, retroperitoneal and hepatic fats
The measurements of visceral fats showed that DLCN accumulated less mesenteric and epidid-
ymal fat respectively (3.43 ± 0.14 g; 2.25 ± 0.14 g) in relation to the other groups (CONT
4.87 ± 0.28 g; 2.92 ± 0.24 g and DL 4.74 ± 0.41 g; 3.13 ± 0.23 g), and in the retroperitoneal
space (2.26 ± 0.12 g) when compared to CONT (3.98 ± 0.43 g) (P< 0.05) (Fig 6). The liver
weight differed between the DLCN (10.33 ± 0.32 g) and DL (10.95 ± 0.58 g) groups as com-
pared to the CONT (9.2 ± 0.17 g) (P< 0.05) (Fig 7).
The quantification of liver fat showed that the DLCN (8.55 ± 0.57 g/100g) accumulated
more fat than the CONT (4.36 ± 0.12 g/100g) and DL (6.45 ± 0.22 g/100g) groups (P< 0.05).
However, the DL group accumulated a higher hepatic fat content than the CONT group
(Fig 7).
Fecal fat
The fat content in the feces was higher in the DL (3.88 ± 0.08 g/100g; 3.56 ± 0.14 g/100g) and
DLCN (3.97 ± 0.20 g/100g; 4.14 ± 0.14 g/100g) groups in relation to CONT (2.78 ± 0.09
g/100g; 2.63 ± 0.11 g/100g) for all collections. However, in the second collection, the DLCN
group (4.14 ± 0.14 g/100g) excreted more fat compared to the other groups (DL 3.56 ± 0.14
g/100g) and CONT (2.63 ± 0.11 g/100g), as illustrated in Fig 8.
Table 4. Physical parameters of dyslipidemic rats treated with cashew nuts.
Parameters CONT DL DLCN P value
Body mass index (g/cm2) 0.527 ± 0.02 0.575 ± 0.01 0.568 ± 0.02 0.154
Abdominal circumference (cm) 17.49 ± 0.25 17.2 ± 0.39 16.45 ± 0.28 0.060
Thoracic circumference (cm) 15.72 ± 0.29 15.05 ± 0.47 14.72 ± 0.27 0.150
Values are expressed as mean ± SEM.
https://doi.org/10.1371/journal.pone.0225736.t004
Fig 4. Biochemical values (mean ± SEM) of dyslipidemic rats fed cashew nut. CONT = Control group,
DL = Dyslipidemic group, DLCN = Dyslipidemic Cashew Nut group. � versus CONT, # versus DL; For all groups,
p< 0.05 was considered a significant difference as determined by One-Way ANOVA followed by the Tukey test.
https://doi.org/10.1371/journal.pone.0225736.g004
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Hepatic and fecal fatty acids
Regarding saturated fatty acids (SFA) present in the liver (Table 5), the DLCN group presented
an increase in the content of Myristic acid (14:0) as compared to DL and a reduction as
Fig 5. Glycaemic curve of oral tolerance test for glucose for dyslipidaemic rats treated with cashew nut and glucose
area under the curve. a) Glycaemic curve of oral tolerance test for glucose; b) glucose area under the curve (AUC).
Values are the mean ± SEM. Groups: CONT = Control group; DL = Dyslipidemic group; DLCN = Dyslipidemic
Cashew Nut group. � versus CONT. p< 0.05, as determined by One-Way ANOVA followed by the Tukey test.
https://doi.org/10.1371/journal.pone.0225736.g005
Fig 6. Weight of visceral fat (mesenteric and epididymal) and retroperitoneal of dyslipidaemic rats fed cashew nut. Values are the mean ± SEM. Control group
(CONT), Dyslipidemic group (DL), Dyslipidemic Cashew Nut group (DLCN). � versus CONT. # versus DL. p< 0.05, as determined by One-Way ANOVA followed by
the Tukey test.
https://doi.org/10.1371/journal.pone.0225736.g006
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compared to CONT. There was a reduction of Palmitic acid (16:0) in the DLCN group com-
pared to the other groups; the highest value was in the DL group. Stearic acid (18:0) resulted in
similar values for DLCN and DL, with lower values than CONT. The DLCN group presented
higher values of Lignoceric acid (24:0) compared to DL, but with no difference from CONT.
Fig 7. Liver fatty and liver weight of dyslipidaemic animals fed cashew nut for four weeks. Values expressed as the
mean ± SEM. The groups were Control group (CONT), Dyslipidemic group (DL), Dyslipidemic Cashew Nut group
(DLCN). � versus CONT. # versus DL. p< 0.05, as determined by One-Way ANOVA followed by the Tukey test.
https://doi.org/10.1371/journal.pone.0225736.g007
Fig 8. Fecal fat of rats treated with a high-fat diet with cashew nut. Rats were divided into the following groups: Control group (CONT), Dyslipidaemic
group (DL) and Dyslipidemic Cashew Nut group (DLCN). The first collection occurred at 14th day of the experiment and the second collection at 35th day of
experiment. � versus CONT. # versus DL, with p< 0.05, determined by One-Way ANOVA followed by the Tukey test, where values are expressed as the
mean ± SEM.
https://doi.org/10.1371/journal.pone.0225736.g008
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In total values of accumulated SFA in the hepatic tissue, the DLCN group presented a reduc-
tion of 20.8% as compared to the CONT group, and of 1.5% as compared to the DL group.
Table 5. Composition of fatty acids (%) present in the liver of rats fed with cashew nuts.
FATTY ACIDS GROUPS
CONT DL DLCN
SATURATED
Myristic acid 14:0 5.02 ± 0.25 2.62 ± 0.26� 4.50 ± 0.30�#
Pentadecanoic acid 15:0 0.11 ± 0.01 0.05 ± 0.01� 0.05 ± 0.01�
Palmitic acid 16:0 15.65 ± 0.20 16.35 ± 0.28� 13.70 ± 0.00�#
Margaric acid 17:0 0.41 ± 0.03 0.29 ± 0.00� 0.31 ± 0.01�
Stearic acid 18:0 19.05 ± 1.05 13.05 ± 0.14� 13.14 ± 0.02�
Arachidic acid 20:0 0.03 ± 0.00 0.04 ± 0.00 0.07 ± 0.00�#
Behenic acid 22:0 0.05 ± 0.01 0.07 ± 0.02 0.12 ± 0.02�#
Lignoceric acid 24:0 0.23 ± 0.01 0.13 ± 0.03� 0.22 ± 0.02#
TOTAL 40.55 32.60 32.11
MONOUNSATURATED
Myristoleic acid 14:1ω5 0.15 ± 0.01 0.12 ± 0.02 0.16 ± 0.01#
Palmitoleic acid 16:1ω7c 0.46 ± 0.01 0.96 ± 0.10� 1.00 ± 0.02�
Heptadenoic acid 17:1ω7c 0.18 ± 0.02 0.13 ± 0.06 0.16 ± 0.03
Trans-Oleic acid 18:1ω9t 0.14 ± 0.00 0.22 ± 0.02� 0.43 ± 0.03�#
Cis-Oleic acid 18:1ω9c 8.53 ± 0.04 19.85 ± 0.14� 24.23 ± 0.06�#
Gondoic acid 20:1ω9 0.05 ± 0.01 0.27 ± 0.07� 0.23 ± 0.04�
Erucid acid 22:1ω9 0.71 ± 0.01 1.33 ± 0.03� 1.41 ± 0.00�#
Nervonic acid 24:1ω9 0.12 ± 0.01 0.12 ± 0.02 0.16 ± 0.02�#
TOTAL 10.34 23.00 27.78
POLYUNSATURATED
Linoleic acid 18:2ω6c 14.91 ± 0.24 20.62 ± 0.23� 18.10 ± 0.02�#
γ-linolenic acid 18:3ω6 0.15 ± 0.04 0.15 ± 0.04 0.13 ± 0.05
α-linolenic acid 18:3ω3 0.09 ± 0.01 0.23 ± 0.07� 0.13 ± 0.06#
Eicosadienoic acid 20:2ω6 0.26 ± 0.03 0.52 ± 0.01� 0.42 ± 0.01�#
Eicosatrienoic acid 20:3ω6c 0.11 ± 0.00 0.06 ± 0.01� 0.05 ± 0.02�
Eicosatrienoic acid 20:3ω3c 0.05 ± 0.03 0.06 ± 0.00 0.06 ± 0.01
Arachidonic acid 20:4ω6c 22.53 ± 0.60 14.56 ± 0.09� 14.33 ± 0.05�
Docosadienoic acid 22:2ω6 0.35 ± 0.19 0.34 ± 0.08 0.29 ± 0.13
Eicosapentaenoic acid 20:5ω3 0.40 ± 0.08 0.56 ± 0.03� 0.21 ± 0.05�
Docosahexaenoic acid 22:6ω3 3.89 ± 0.17 3.53 ± 0.05� 2.81 ± 0.05�#
TOTAL 42.74 40.63 36.53
PUFA/SFA 1.05 1.25 1.14
S ω3 4.43 4.38 3.21
S ω5 0.15 0.12 0.16
S ω6 38.31 36.25 33.32
S ω7 0.64 1.09 1.16
S ω9 9.55 21.79 26.46
ω6/ω3 8.65 8.28 10.38
Values are expressed as mean ± SEM. CONT = Control Group; DL = Dyslipidemic Group; DLCN = Dyslipidemic Cashew Nut Group; S = sum;
PUFA = Polyunsaturated Fatty Acids; SFA = Saturated Fatty Acids.
� vs CONT.
# vs DL. Statistical test used was One-Way ANOVA followed by Tukey with level of significance (p <0.05).
https://doi.org/10.1371/journal.pone.0225736.t005
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As for the amount of monounsaturated fatty acids (MUFA) present in the liver, DLCN pre-
sented a higher value of Myristoleic acid (14:1ω5) as compared to DL. DLCN also presented
higher values of Trans-oleic acid, Cis-oleic acid, Erucid and Nervonic acids (18:1ω9t, 18:1ω9c,
22:1ω9 and 24:1ω9) in relation to the other groups. The sum of the MUFA averages showed an
increase of 168% for the DLCN group in relation to the CONT group and 21% in relation to
the DL group. The total content of ω-9 fatty acids was higher in the DLCN group as compared
to the other groups, with an elevation of 177% in relation to CONT, and 21% in relation to LD.
The polyunsaturated fatty acid Linoleic acid (18:2ω6c) presented elevated values (by about
17% for DLCN) when compared to CONT, and a higher quantification in the DL group as
compared to the other groups. Arachidonic acid (20:4ω6c) presented similar values for the
DLCN and DL groups, with a reduction in the CONT group. The fatty acid Eicosapentaenoic
acid (20:5ω3) presented increasing values for DLCN, CONT and DL in order. The Docosahex-
aenoic acid (22:6ω3) values were lower in the DLCN group and higher in the CONT group.
The total polyunsaturated fatty acids (PUFA) in the liver presented a slight percentage differ-
ence between the groups, with DLCN presenting a 14.5% reduction as compared to CONT,
DL presenting a 4.9% reduction as compared to CONT, and DLCN presenting a 10% reduc-
tion as compared to DL.
Our data show in Table 6 that fecal excretion of fatty acids varied between groups in both
feces collections. The data from the first collection, performed on the last day of dyslipidemia
induction, show an increase in saturated fats for the groups that consumed the emulsion with
high fat content. However, in the second collection there was a marked decrease in saturated
fat excretion by the DLCN group as compared to the other groups, and a difference of 10.6%
was observed in relation to the DL group. MUFA quantification presented similar levels
between the two collections and between the groups. Regarding PUFA, there was a reduction
in the second collection as compared to the first for the CONT and DL groups, but the DLCN
presented lower levels of polyunsaturated fats in the feces for both the first and second collec-
tions in relation to the other groups.
Discussion
Consumption of seed oils (pleasant flavors and high caloric values) is related to body weight
gain [25]; but the fiber content of this food also acts on satiety, causing hypophagy, and conse-
quent reduction of ingested energy [26]. Increased energy density in a diet with high lipid
value, such as Cashew nut consumption with an emulsion rich in SFA and cholesterol as used
in the present study also causes increased satiety [27], with consequent reductions in the appe-
tites of the rats [28]. These findings justify the results of the present study in relation to the
delay in weight gain and lower calories and feed intake by the groups that underwent induc-
tion of dyslipidemia (Table 3, Figs 2 and 3). However, in the DLCN animals, the result was
even more evident, since the consumption of Cashew nuts caused lower calories and feed
intake as compared to the other experimental groups, most evident in the last experimental
weeks (Table 3 and Fig 3).
When assessing appetite sensations in humans ingesting almonds and walnuts, levels of
hunger were found to be suppressed and satiety increased [29, 30]. Like almonds and other
nuts, Cashew nuts present high lipid and protein contents, as well as fibers which are associ-
ated with reduced appetite [29].
The supplementation of fibers in rats fed a diet rich in fats has also caused a decrease in ani-
mals’ weights, but with increased consumption [31, 28]. Another factor associated with alter-
ation of satiety is the profile and amount of fatty acids in the lipid source consumed; these
eventually flow through the bloodstream and affect satiety in the brain. After triacylglycerol
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hydrolysis of foods, fatty acids are transported to epithelial cells in the form of micelles to be
absorbed. Depending on the degree of fat insaturation, micelle formation becomes faster; UFAs
are more readily available for absorption, causing release of hormones and increased satiety [32].
Kozimor et al. [33], evaluated satiety in women receiving a diet rich in SFA, MUFA, and
PUFA and it was observed that PUFAs promoted greater satiety in comparison to SFAs. In the
Table 6. Composition of fatty acids (%) present in the feces of dyslidemics rats fed with cashew nuts.
FATTY ACIDS GROUPS
CONT DL DLCN
14th day 35th day 14th day 35th day 14th day 35th day
SATURATED
Myristic acid 14:0 8.47 ± 0.02 9.19 ± 0.28 10.80 ± 0.33� 9.39 ± 0.60 9.99 ± 0.56�# 10.85 ± 0.84�#
Pentadecanoic acid 15:0 1.70 ± 0.14 3.11 ± 0.24 1.26 ± 0.25� 2.16 ± 1.13� 1.95 ± 0.18# 2.61 ± 0.25�#
Palmitic acid 16:0 16.02 ± 0.13 16.97 ± 0.24 14.97 ± 0.06� 15.78 ± 0.36� 16.42 ± 0.18�# 14.63 ± 0.19�#
Margaric acid 17:0 0.10 ± 0.01 0.24 ± 0.02 0.05 ± 0.03� 0.16 ± 0.06 0.19 ± 0.02�# 0.35 ± 0.12#
Stearic acid 18:0 15.24 ± 0.34 9.95 ± 0.20 15.25 ± 0.13 16.78 ± 0.01� 16.04 ± 0.15�# 11.35 ± 0.32�#
Arachidic acid 20:0 0.73 ± 0.03 1.05 ± 0.04 0.52 ± 0.04� 0.97 ± 0.16 0.49 ± 0.08� 0.63 ± 0.14�#
Behenic acid 22:0 0.65 ± 0.01 1.01 ± 0.04 0.40 ± 0.04� 0.65 ± 0.00� 0.52 ± 0.00�# 0.43 ± 0.00�#
Lignoceric acid 24:0 0.99 ± 0.03 1.91 ± 0.02 0.79 ± 0.05� 1.23 ± 0.07� 0.74 ± 0.01� 1.27 ± 0.16�
TOTAL 43.9 43.43 44.04 47.12 46.34 42.12
MONOUNSATURATED
Myristoleic acid 14:1ω5c 2.41 ± 0.01 2.35 ± 0.15 1.91 ± 0.23� 1.88 ± 0.17� 2.22 ± 0.20# 2.61 ± 0.04�#
Pentadecenoic acid 15:1ω5c 0.33 ± 0.03 0.49 ± 0.00 0.19 ± 0.05� 0.33 ± 0.03� 0.20 ± 0.03� 0.43 ± 0.02�#
Palmitoleic acid 16:1ω7c 0.50 ± 0.06 0.58 ± 0.00 0.42 ± 0.11 0.62 ± 0.09 0.61 ± 0.09# 0.66 ± 0.17
Oleic acid 18:1ω9t 2.39 ± 0.05 3.64 ± 0.11 1.82 ± 0.01� 2.12 ± 0.14� 2.06 ± 0.01�# 0.97 ± 0.18�#
Oleic acid 18:1ω9c 16.36 ± 0.25 15.13 ± 1.02 16.04 ± 1.41 14.59 ± 0.97 15.92 ± 0.28 16.50 ± 0.05�#
Erucid acid 22:1ω9 0.18 ± 0.05 0.28 ± 0.06 0.18 ± 0.02 0.20 ± 0.00� 0.15 ± 0.07 -
TOTAL 22.17 22.47 20.56 19.74 21.16 21.17
POLYUNSATURATED
Linoleic acid 18:2ω6c 20.69 ± 0.05 19.34 ± 0.32 18.92 ± 0.28� 17.84 ± 0.79� 18.17 ± 0.27�# 17.48 ± 0.18�#
γ-linolenic acid 18:3ω6 0.33 ± 0.08 0.16 ± 0.05 0.23 ± 0.02� 0.18 ± 0.08 0.26 ± 0.02� 0.16 ± 0.03
α-linolenic acid 18:3ω3 0.82 ± 0.00 0.73 ± 0.00 1.04 ± 0.00� 0.84 ± 0.00� 0.57 ± 0.00�# 0.39 ± 0.00�#
Eicosadienoic acid 20:2ω6 0.17 ± 0.01 0.15 ± 0.05 0.19 ± 0.02 0.29 ± 0.04� - -
Arachidonic acid 20:4ω6c 0.26 ± 0.00 0.26 ± 0.01 0.48 ± 0.07� 0.41 ± 0.02� 0.43 ± 0.08� 0.35 ± 0.09�
Eicosapentaenoic acid 20:5ω3 0.46 ± 0.05 0.41 ± 0.03 0.76 ± 0.07� 0,57 ± 0.01� 0.50 ± 0.03# 0.76 ± 0.00�#
Docosahexaenoic acid 22:6ω3 0.36 ± 0.14 0.62 ± 0.05 0.77 ± 0.07� 0.48 ± 0.06� 0.64 ± 0.03� 1.08 ± 0.14�#
TOTAL 23.09 21.67 22.39 20.61 20.57 20.22
PUFA/SFA 0.52 0.50 0.51 0.44 0.44 0.47
S ω3 1.64 1.76 2.57 1.89 1.71 2.23
S ω5 2.74 2.84 2.10 2.21 2.42 3.04
S ω6 21.45 19.91 19.82 18.72 18.86 17.99
S ω7 0.50 0.58 0.42 0.62 0.61 0.66
S ω9 18.93 19.05 18.04 16.91 18.13 17.47
ω6/ω3 13.08 11.31 7.71 9.90 11.03 8.07
Values are expressed as mean ± SEM. The first collection occurred at 14th day of the experiment and the second collection at 35th day of experiment. CONT = Control
group; DL = Dyslipidemic Group; DLCN = Dyslipidemic Cashew Nut Group; S = sum; PUFA = Polyunsaturated Fatty Acids; SFA = Saturated Fatty Acids.
� vs CONT.
# vs DL. Statistical test used was One-Way ANOVA followed by Tukey with level of significance (p <0.05).
https://doi.org/10.1371/journal.pone.0225736.t006
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study, MUFAs presented a lower satiety response as compared to the other two types of fat.
Poudyal and collaborators [34] concluded that supplementation with differing oils such as:
“macadamia oil, safflower oil, and linseed oil, being respectively rich in oleic, linoleic, and α-
linolenic acids, reduced feed intakes as compared to groups fed a normal diet. A study compar-
ing a diets rich in saturated and unsaturated fats, found higher weights in rats fed a diet rich in
saturated fats, even with the same calorie intake for both groups [35].
The Cashew nuts used in this research presented excellent total phenolic content and total
flavonoids; as well as a high catechin content, seen in Tables 1 and 2, giving it a high nutritional
quality [36]. According to Trox et al. [37], Cashew nuts present high antioxidant potential
because they are a source of phenolic compounds which possess biological and medicinal
properties. Like other oleaginous foods, the total phenolic content and total flavonoids found
in Cashew nuts are highlighted for their functional properties [38, 39], being responsible for
inhibiting or reducing oxidation, and resulting in UFA protection [40]. However, Cashew
nuts’ antioxidant content can be diminished through heat treatment, percentage of shell pres-
ent, storage, and irradiation processes [40]. Studies show the potential value of Anacardium
occidentale as a source of antioxidants not only in the fruit, but also in its leaves and pseudo-
fruits [41, 42].
The induction of dyslipidemia as performed in the present study proved to be effective,
since the treatment induced an increase in TC in both treated groups (DL and DLCN) (Fig 4).
However, the consumption of Cashew nuts did not reverse the effects caused by the adminis-
tration of a high fat content emulsion. The Cashew nuts used in the present study presented a
total dietary fiber content of 3.65 g per 100 g of product, (with 0.33 g of soluble and 3.32 g of
insoluble fibers). Soluble fibers are widely used in the treatment of dyslipidemias [43, 44]. In
contrast, insoluble fiber consumption does not present positive effects for cholesterol reduc-
tion or cardiovascular risk [14]; as verified in the present study, because there were no
observed reductions in TC or TG.
The hypocholesterolemic action caused by consumption of seed oils still diverges in many
studies. Lovejoy et al. [45], evaluated non-diabetic adult males and females who consumed 100
g of almonds/day for 4 weeks. A reduction in TC by 21% was observed. Similarly, Lee et al. [46]
reported improvement of TC levels in women with metabolic syndrome who consumed a nut
mixture for 6 weeks. However, Casas-Agustench et al. [26], when assessing the effect of a seed
oil mixture (walnuts, almonds and hazelnuts), in conjunction with a standard diet in adult men
and women with metabolic syndrome observed (after 12 weeks) no alterations in TC, LDL,
HDL and TG. When evaluating the administration of Cashew leaf, stem and nut extract, Jaiswal
et al. [47], reported no significant differences in TC and HDL levels in diabetic rats.
In the present study, the HDL levels in the dyslipidemic group decreased in comparison to
the control group. However, in the animals treated with Cashew nuts, which also suffered
prior induction of dyslipidemia, the damage was reversed. The DLCN presented values similar
to the control group (which did not suffer from induction of dyslipidemia) (Fig 4), thus
highlighting the beneficial effects of Cashew nuts on HDL levels.
Evaluating the glycemic metabolism of the animals in the present study through fasting gly-
cemia, the group treated with Cashew nuts presented higher values as compared to the other
groups (Fig 4). In the oral glucose tolerance test, the groups DL and DLCN presented elevated
levels of serum glucose at the beginning and end of the test (time 0, 30 and 45 minutes) (Fig
5A), this can be confirmed in Fig 5B with the glucose area over the OTTG curve. However, the
curve shows that DL had higher serum glucose levels. Studies evaluating seed oil consumption
in humans have observed a reduction in fasting glycemia in diabetic individuals [48, 49, 45].
However, Ma et al. [50], when treating diabetic men and women with nuts, verified an increase
in fasting glycemia.
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Research also performed with humans presents results similar to the present study when
performing the OGTT, confirming an increase in serum glycemia in men and women diag-
nosed with metabolic syndrome and treated with Cashew nuts for 8 weeks [51]. When testing
a diet with high fat content, Almeida-Suhett et al. [52], also found an increase in basal glycemia
in rats, resulting in a glucose tolerance curves with greater areas in the animals fed the high fat
content diets.
Regarding serum TG levels, DLCN presented a decrease of 36.3% in relation to the dyslipi-
demic group and a 23% elevation as compared to the control group. Because they are a source
of UFA, Cashew nuts promote a fall in TG because they potentially reduce exposure of non-
esterified fatty acids to the liver, preventing one of the main TG synthesis pathways [53]. How-
ever in this study, Cashew nuts were not able to completely ablate such alterations as compared
to the control group.
Alterations in carbohydrate metabolism interfere in the lipid profile, because when glucose
appears in excess, insulin converts it into fatty acids which are stored in the form of TG, (their
concentration becomes elevated and HDLs are reduced). Elevation of TG levels implies pan-
creatic β cell apoptosis due to lipotoxicity, causing insulin resistance [54]. Thus, elevation of
serum TG levels correlates with high fasting glucose levels and the OGTT results in this study.
The induction of dyslipidemia and the consumption of Cashew nuts may have triggered
increased glycemic levels which interfere with lipid metabolism.
A diet rich in lipids, such as the one used in the present study, causes the organism to accu-
mulate excess fat, with adipocyte expansion, high blood concentrations of serum lipids and
lipoproteins, and high lipid supplies to the liver. Lipid superaccumulation results in the ectopic
deposition of lipids in non-adipose tissues, and increases hepatic gluconeogenesis; along with
LDL and HDL reductions [55, 56].
In our study, the animals of the DL and DLCN groups were kept on a fat-rich diet, and the
DLCN group received Cashew nuts (in addition) which also have high lipid content. The data
revealed that supplementation with Cashew nuts induces a lower deposition of fatty acids in
the adipose tissues, besides promoting a decrease in serum TG. The data correlate when con-
sidering that TG are stored in the adipose tissue and that deposition is directly related to its
synthesis in the liver and its concentration in the bloodstream [57].
However, reduction in fat deposition was not observed in the liver, since there was a higher
accumulation of fats in the DLCN than in the DL. Evaluating the fatty acids profile as accumu-
lated in this tissue, a difference was observed; the group that received Cashew nuts presented
more MUFA in relation to the DL group.
Considering that the DLCN group received fatty acids (originating in Cashew nuts) in addi-
tion to the dietary fatty acids which the DL group also received. Cashew nut supplementation
inhibited fat accumulation in adipose tissue as compared to DL. However, when analyzing the
glycemic curve we also found an increase in plasma glycemia. According to Kahn and Valdez
[55], a fat-rich diet can generate free fatty acid deposition in the pancreas; reduce insulin secre-
tion, inducing insulin resistance, or hyperglycemia. This potentially occurred in the present
study, since there was an increase in the glycemic curve and in fasting hyperglycemia.
When the physical condition of the animals was evaluated, it was found that the Cashew
nuts offered to the animals caused (besides reduction of body weight) a reduction of visceral
(mesenteric and epididymal) and retroperitoneal fats (Fig 6). Vaidya et al. [58] evaluated the
effect of omega 3 fatty acid supplementation in rats with a fat-rich diet, and observed reduc-
tions in body fat in animals treated for 8 weeks. The same research observed reduction of body
weight, reduction of liver weight, reduction of TC, and of hepatic cholesterol. Bhaskaran et al.
[35], when treating rats with saturated and unsaturated fats found a reduction in the size of the
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adipocytes of the group fed with a diet rich in unsaturated fat. These studies corroborate our
findings, where Cashew nuts, a source of unsaturated fats, produced the same results.
Fat-rich diets also induce adipose tissue accumulation; which causes the increase of free
plasmatic fatty acids [59]. The release of free fatty acids from visceral adipose tissues contrib-
utes to fat oxidation, and stimulates esterification of fatty acids into TGs in the liver. This leads
to reductions in glucose and lipid metabolism in the peripheral tissues [60]. Our research pre-
sented reductions of visceral and retroperitoneal fats in the group treated with Cashew nuts. In
contrast, there was an increase in serum TG (as compared to the control group) and higher
liver fat accumulation, which might be explained by increased oxidation of fatty acids and
reduction of lipogenesis, which uses peripheral tissue fats [35].
The hepatic fat content measured followed the organ weight; since as fat deposition
increases, there is an increase in organ weight. Our findings evidenced greater deposition of
hepatic fat in the group treated with Cashew nuts as compared to the other groups (CONT
and DL), but the liver weight increased in both dyslipidemic groups (DLCN and DL) as com-
pared to CONT (Fig 7). Cholesterol and TG synthesis is highest in the liver, and the main sites
of fat deposition are in the viscera and under the skin.
In this study, the animals that consumed Cashew nuts presented lower abdominal fat depo-
sition. Both dyslipidemic groups presented a higher percentage of liver fat, with the highest
amount found in DLCN. The correlation of hepatic fat deposition with quantification of fatty
acids revealed that when comparing the DLCN with the DL, the amounts of SFA were similar;
with the MUFA contents being 21% higher in the DLCN. These results are possibly due to
Cashew nuts being a source of oleic acid. The consumption of Cashew nuts induced greater
hepatic deposition of MUFA. As in our research, Picklo et al. [61], also found an increase in
oleic acid in the livers of rats with a high-fat oleic acid diet; as well as an elevation of liver fats
and glycemia for these animals.
High depositions of inappropriate ectopic fat in the liver generate hepatic steatosis or non-
alcoholic fatty liver disease (NAFLD) [57], a disease with negative impacts on the health of
obese individuals, and usually accompanied by dyslipidemia and other complications [58, 62].
Lee Homma and Fujii [63] showed that the early phase of non-alcoholic fatty liver disease
(NAFLD) presents protective functions against oxidative lesions caused by reactive oxygen
species (ROS) and toxic agents in rats when fed a diet rich in unsaturated fat, because this tem-
porary accumulation of liver fat is an adaptive response of hepatocytes under stress. Research
comparing the accumulation of liver fats as related to the consumption of SFA, (with a palm
oil based diet), and UFA, (with sunflower oil-based diet) in adult men and women concluded
that a UFA rich diet prevents liver, visceral, and total fat deposition as compared to the SFA
rich diet. This was not observed in the present study [53].
The Cashew nuts used in this research are a source of oleic acid and linoleic acid, however,
since it was offered to previously dyslipidemic animals and this continued with consumption
of a hyperlipid emulsion, the Cashew nut consumption was not able to reverse liver fat accu-
mulation or to improve the fatty acid profile in the tissue, with the exception of the MUFA.
In the first collection, the amount of fat excreted in the feces was higher in the DL and
DLCN groups than in the CONT group, due to induction of dyslipidemia through administra-
tion of a high fat content emulsion. However, in the second collection, (after initiation of treat-
ment with Cashew nuts), there was a higher amount of fat excretion by DLCN as compared to
CONT and DL (Fig 8). The use of fibers in the diet assists in the excretion of fat through the
feces [64]. Cashew nuts, in addition to containing dietary fibers, are a food source of UFAs,
especially oleic and linoleic acids. High fat intake, (as in the case of the animals in the DL
group), induced higher fecal fat excretion, and the consumption of Cashew nuts (which is a
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source of fibers) also caused an increase in excretion. The soluble fibers form a chelate with the
fat being excreted by the gallbladder or consumed in the diet [65].
Thus, in the present study, the data confirm that the fibers and lipid content of Cashew nuts
were responsible for the increase in fecal fat excretion. When using seed oils (walnuts, almonds
and hazelnuts) in research with adult individuals, Casas-Agustench et al. [26] found higher
excretion of fecal fat when compared to the control group. Research evaluating dietary fiber
contents, found that a diet supplemented with flaxseed increased fat excretion by up to 50%
[64]. Even with increased fat excretion, DLCN showed high total cholesterol, but this group
consumed largely unsaturated cashew lipids, which may be responsible for increasing the
HDL content compared to DL.
When correlating the data of this study, we found that Cashew nuts in a dyslipidemic diet
(DLCN), in relation to the group without Cashew nuts (DL), led to reversal of HDL serum lev-
els, weight reduction, visceral and retroperitoneal fat deposition, higher liver fat deposition (of
a better quality) and increased excretion of fecal fat. However, we also found increased serum
levels of total cholesterol, together with glucose.
Conclusion
Previously dyslipidemic animals, maintained on saturated fats associated with Cashew nuts,
presented reductions in visceral and retroperitoneal fat deposition, and a reversal of dimin-
ished HDL levels usually found in dyslipidemias. However, treatment with Cashew nuts com-
promised glycemic metabolism, and augmented fat deposition in the hepatic tissue.
We conclude that consumption of Cashew nuts by dyslipidemic animals in an unbalanced
diet presents improvements in dyslipidemia, yet also increases glycemic alterations, and raises
risks of non-alcoholic fatty liver disease.
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